LETTER TO EDITOR
|Year : 2009 | Volume
| Issue : 2 | Page : 133-134
Therapeutic paradox in CNS tuberculosis
Geetanjali Jindal1, Debabrat Ghosh2
1 Department of Pediatrics, Government Medical College, Sector 32, Chandigarh, India
2 Cleveland Clinic Main Campus, Mail Code S71, 9500 Euclid Avenue, Cleveland, OH 44195, USA
|Date of Web Publication||29-Oct-2009|
1203, Sector 32-B (GMCH, Doctors' Complex), Chandigarh
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Jindal G, Ghosh D. Therapeutic paradox in CNS tuberculosis. J Pediatr Neurosci 2009;4:133-4
A 7 year old male child presented with a progressive illness characterized by fever (4 months), headache (2 months), vomiting (1 month), altered sensorium (7 days) and generalized tonic clonic seizures for a day. There was a family history of tuberculosis. He had neck rigidity with brisk deep tendon reflexes. CT scan revealed hydrocephalus due to an obstruction between the third and the fourth ventricle with basal exudates. Lumbar CSF showed 120 cells with 90% lymphocytes, proteins of 208 mg% and CSF sugar of 31 mg% against blood sugar of 61 mg%. CSF smears and cultures were negative. On the basis of prolonged history, positive family history and lymphocytic predominance in CSF, a diagnosis of tubercular meningitis was made. The child was started on four-drug anti-tubercular therapy (rifampicin, isoniazid, pyrazinamide and ethambutol) and compliance to drug therapy was ensured. A ventriculo-peritoneal shunt was inserted and it resulted in a significant neurological improvement. He remained well for about 6 months after which he presented with headache for 10 days, difficulty in walking for 7 days and fever for 4 days. The sensorium was normal. There were no signs of meningeal irritation or raised intracranial pressure. There was right-sided ptosis, marked truncal ataxia with some signs of limb ataxia, more so on the right side. The representative sections of MRI of the head are illustrated in the [Figure 1],[Figure 2],[Figure 3].
The possible reasons for the secondary deterioration were:
- Ventriculo-peritoneal shunt malfunction: Headache and cerebellar signs could be explained due to shunt malfunction but right eye ptosis couldn't be explained.
- Development of stroke in posterior circulation on the top of the basilar artery territory. There was no history of acute onset to suggest stroke. Moreover, the stroke in tuberculous meningitis tends to manifest during the early part of the disease process, whereas the secondary deterioration in the index case occurred after an asymptomatic period of 6 months.
- Similarly, secondary resistance of Mycobacterium tuberculosis antitubercular drugs is unlikely as there was an excellent response. There were no signs of meningeal irritation. The child enjoyed an asymptomatic period of 6 months before secondary deterioration. Moreover, the compliance to anti-tubercular therapy was ensured.
- The paradoxical appearance of tuberculomas, whilst on antitubercular therapy seems most likely. A greater severity of truncal vis-à-vis limb ataxia denotes vermian or paravermian cerebellar involvement or its connecting pathway.  Right eye ptosis without extraoccular muscle paresis or pupillary abnormalities indicates partial third nerve palsy or levator palpebral superioris subnucleus involvement in the high midbrain (intra-axial). Lesion in the supranuclear pathway on the opposite site can also explain predominantly unilateral ptosis. 
T1 weighted axial section [Figure 1] shows hypo intense lesions in left side of midbrain, cerebellar vermian region and in the anterior part of the left temporal lobe. The right temporal horn of the lateral ventricle is dilated. On gladolinium enhancement [Figure 2], there are conglomerate ring enhancing lesions in the above-mentioned areas. In T2 weighted axial section [Figure 3], there is hyper intensity in the above-mentioned areas and most of the left temporal lobe. In addition, there are a few lesions with a central hyperintensity and a peripheral hypointense ring; these findings are consistent with a radiological diagnosis of multiple tuberculomas. 
The development of tuberculomas in cases of tuberculous meningitis whilst on anti-tubercular therapy, and in spite of satisfactory compliance is designated as paradoxical response or therapeutic paradox. This therapeutic aberration usually occurs in the initial 2-3 months of therapy and generally coincides with the tapering of steroids.  However, cases have been reported up to 18 months after starting anti-tubercular therapy.  The probable explanation for development of fresh tuberculomas or an increase in size of pre-existing lesions, in spite of effective chemotherapy, is a consequence of interplay between the hosts`immune responses and the effects of mycobacterial products. Active tuberculosis can result in suppression of delayed type hypersensitivity responses (anergy). Once active TB is under control and immunosuppression is resolved, enhanced delayed type of hypersensitivity can lead to activation and accumulation of lymphocytes and macrophages at the site of bacillary deposition or toxin production when the bacilli die. If the activation occurs at the site of microscopic foci in CNS, tuberculomas appear. If it occurs at the site of macroscopic tuberculomas, they enlarge. 
The introduction of oral steroids leads to a very good response. In the index case, the headache became passive within 2 days and the gait abnormalities started improving to become passive over a few days after the addition of steroids to same anti tubercular drug regimen. Right eye ptosis disappeared and truncal and limb ataxia also became passive. There is no evidence that a change in anti-tubercular drug regimen therapy is warranted as exemplified in our case. The anti-inflammatory effects of steroids diminish the neurological symptoms over a short period. 
Paradoxical appearance of tuberculomas whilst on antitubercular therapy.
- Appearance or increase in the size of tuberculomas may occur during therapy.
- The phenomenon usually manifests within initial few months, but is known to occur till as late as 18 months after start of anti-tubercular therapy.
- The phenomenon has an immunological basis and responds to a short course of steroids.
- A change in therapy or a prolonged duration of therapy is not warranted
| References|| |
|1.||The extrapyramidal system and the cerebellum. In: Neurological differential diagnosis, ed Patten J, 2 nd edn. London: Springer; 2000. pp 178-212. |
|2.||The Eyelids and the Extraoccular Muscles. In: Clinical Neuro-Opthalmology, ed Walsh FB, 2nd edn. Baltimore: Williams and Wilkins company, 1957. pp 185-275. |
|3.||Katariya S. CNS Infections. In: Diagnostic Radiology, Neuroradiology Including Head and Neck Imaging, eds Berry M, Suri S, Chowdhury V et al, 1 st edn. New Delhi: Jaypee Brothers, 2001. pp 44-65. |
|4.||Abduljabbar M. Paradoxical response to chemotherapy for intracranial tuberculoma: two case reports from Saudi Arabia. Journal of Tropical Medicine and Hygiene 1991, 94: 374-376. [PUBMED] [FULLTEXT] |
|5.||Prakash Rao G, Rajendra Nadh B, Hemaratnam A et al. Paradoxical progression of tuberculous lesions during chemotherapy of central nervous system tuberculosis. Journal of Neurosurgery 1995,83: 359-362. |
|6.||Afghani B and Lieberman JM. Paradoxical enlargement or development of intracranial tuberculomas during therapy: Case report and review. Clinical Infectious Diseases 1994, 19: 1092-1099. |
[Figure 1], [Figure 2], [Figure 3]
|This article has been cited by|
||Paradoxical reaction in HIV negative tuberculous meningitis
| ||Ravindra Kumar Garg,Hardeep Singh Malhotra,Neeraj Kumar |
| ||Journal of the Neurological Sciences. 2014; 340(1-2): 26 |
|[Pubmed] | [DOI]|
||Ophthalmic manifestations of central nervous system tuberculosis-two case reports
| ||Lolly, P. and Rachita, S. and Satyasundar, M. |
| ||Indian Journal of Tuberculosis. 2011; 58(4): 196-198 |
||Immunostimulation in the era of the metagenome
| ||Amy D Proal, Paul J Albert, Greg P Blaney, Inge A Lindseth, Chris Benediktsson, Trevor G Marshall |
| ||Cellular and Molecular Immunology. 2011; |
|[VIEW] | [DOI]|